an aqueous phase, is specific and sensitive. The detection limit is <6 g/L (2.3 X 10-8 mol/L). Within-day and between-day coefficients of variation are 1.8 and 4.4%, respectively. Commonly used drugs, including procainamide, N-acetylprocainamide, and quinidine, do not interfere.
Additional Keyphrases: "high-pressure" liquid chromatography
drug assay #{149} monitoring therapy . heart disease Propranolol ("Inderal," Ayerst), a beta-adrenergic blocker, is widely used to treat angina pectoris, certain cardiac arrhythmias, and hypertension.
Although the clinical significance of plasma drug concentrations in various disease states
is not yet completely defined, therapeutic monitoring of propranolol is of value in selected patients, and requests for this assay are likely to increase.
The procedure most widely used for measuring propranolol in plasma has been the double-extraction fluorometric technique of Shand et al. (1) . Although this procedure has been criticized for the lack of specificity inherent to this type of assay (2) pipettes to clean test tubes, dehydrated over anhydrous Na2SO4, decanted into 12-mL conical centrifuge tubes, and evaporated under nitrogen. The residue was dissolved in 50 sL of phosphate buffer, 0.5 mL of hexane was added, and the mixture was shaken and centrifuged.
Materials and Methods

Apparatus
All of the aqueous (lower) phase was transferred to a "nipple" tube (Concentratubes; Laboratory Research Co., P.O. Box 36509, Los Angeles, CA 90836) and after a brief centrifugation, 20 zL of the aqueous phase was chromatographed.
Chromatographic conditions: For elution we used acetonitrile/phosphate buffer (pH 2.7), 25/75 by volume, at a flow rate of 1.5 mL/min and oven temperature (14, 15) . This metabolite is not evident in the plasma after intravenous administration of propanolol, but its apparent effect is detectable shortly after oral therapy. Walle et al. (6) and others (14) have noted that 4-hydroxypropranolol is extremely unstable, and the former workers recommend addition of sodium bisulfite to plasma to prevent deterioration of this metabolite.
Although, in our hands, the unextracted compound showed good liquid-chromatographic behavior, we found that analytical recovery from plasma was too variable and (or) losses too unpredictable, even with use of more polar extraction solvent and even after addition of sodium bisulfite, for us to recommend its measurement at this time.
A report of the HPLC measurement of 4-hydroxypropranolol by Nation et al. (9) and much shorter biological half-life as compared to that of the parent drug (10, 11 
